ALR Technologies Inc. (ALRT-OTC: BB)
Interview with: Stanley Cruitt,
President, Director and Member of the
Audit Committee
Business News, Financial News, Stocks, Money & Investment Ideas, CEO Interview
and Information on their medical reminder products and
compliance monitoring and health intervention systems, addressing the growing problem of
patient adherence to medical disease management treatments and activities. |
CEOCFO
Members Login
Become A Member!
Cover Story
CEOCFO Current Issue
Cover Story Archives
Private Equity Review
CEOCFO Interview Index
Analyst Interviews
Corporate
Financials
Contact
& Ordering |
This is a printer friendly page!
ALR Technologies is
preparing to make commercially available the ALRT500 and Home Health System, a disease management
compliance reminder and monitoring system that allows healthcare providers and caregivers
access to monitor a patient’s compliance to their medication regimen and intervene
when necessary
Patient adherence to medical disease management treatments and activities are contributing
to more than $140 billion dollars annually in excess healthcare costs
Services
Medical Equipment
(ALRT-OTC: BB)
ALR Technologies Inc.
Stanley Cruitt
President, Director and
Member of the Audit Committee
Interview conducted by:
Walter Banks, Publisher
CEOCFOinterviews.com
February 23, 2006
disclaimers
Any reproduction or further distribution of this
article without the express written consent of CEOCFOinterviews.com is prohibited.
|
“This is
the whole crux of the issue; the problem with non-compliance in disease management
activities is very prevalent in the U.S. This leads to a person not taking the medication,
not taking the activities or treatments, and when they do not, their health can fail or
they do not improve. When they do not improve or their health starts to fail, that leads
to an ER visit, escalating costs and a worsening health condition. This is one of the key
contributors to escalating costs in healthcare in the United States. It is estimated that
over $140 billion annually in excess and preventable costs are due to just medication
non-compliance. In addition, this number is higher when noncompliance of treatments and
diagnostics are included.” - Stanley Cruitt |
